Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab +/- Radiotherapy in Relapsed/Refractory Follicular Lymphoma
NCT03465891Phase 2Terminated
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in follicular lymphoma (FL), sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 2018; status: terminated.
02
Drugs
atezolizumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT03465891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03465891.